Format

Send to

Choose Destination
Clin Endocrinol (Oxf). 2016 Jan;84(1):107-14. doi: 10.1111/cen.12936. Epub 2015 Oct 2.

Effects of intermission and resumption of long-term testosterone replacement therapy on body weight and metabolic parameters in hypogonadal in middle-aged and elderly men.

Author information

1
Institute of Urology and Andrology, Segeberger Kliniken, Norderstedt, Germany.
2
Gulf Medical University, Ajman, UAE.
3
Dresden International University, Dresden, Germany.
4
Global Medical Affairs Men's Healthcare, Bayer Pharma AG, Berlin, Germany.
5
Department of Epidemiology and Statistics, Boston University School of Public Health, Boston, MA, USA.
6
Department of Internal Medicine, Endocrine Section, VU medical Center, Amsterdam, The Netherlands.

Abstract

OBJECTIVE:

In addition to primary and secondary ('classical') hypogonadism, hypogonadism occurring in middle-aged and elderly men has been recognized. There is evidence that restoring T levels to normal improves body weight, serum lipids and glucose levels.

DESIGN:

Observational registry study.

PATIENTS:

Two hundred and sixty-two hypogonadal, middle-aged and elderly, men received testosterone replacement treatment (TRT). After having been on TRT for a mean duration of 65·5 months, TRT was temporarily intermitted in 147 patients for a mean of 16·9 months (Group I) due to cost reimbursement issues and in seven men due to prostate cancer. All these men resumed TRT for a mean period of 14·5 months. Of the cohort, 115 men were treated continuously (designated as Group C). To compare on-treatment to off-treatment periods, three periods of equal duration were defined: pre-intermission (on TRT), during intermission (off TRT) and post-intermission (on TRT after resumption of TRT). For proper comparison, the same periods were analysed for those patients who continued TRT throughout (Group C).

MEASUREMENTS:

Variables of body weight, glucose metabolism, lipids, blood pressure and C-reactive protein (CRP).

RESULTS:

In Group C there was a continuous improvement of body weight, serum lipids, glucose, HbA1c , blood pressure and CRP. In Group I there was a similar initial improvement which was reversed upon intermission of T administration but which appeared again when T treatment was reinstated.

CONCLUSIONS:

Our observation indicates that T administration improves body weight and metabolic factors in men with hypogonadism but withdrawal of T reverses these beneficial effects to appear again when TRT is resumed.

PMID:
26331709
DOI:
10.1111/cen.12936
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center